151 – 160 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
HESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation
- Contribution to journal › Article
-
Mark
iPSCs: 10 Years and Counting
- Contribution to journal › Debate/Note/Editorial
-
Mark
10 Questions : Clinical Outlook for iPSCs
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
- Contribution to journal › Article
-
Mark
Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.
- Contribution to journal › Article
-
Mark
GDNF is not required for catecholaminergic neuron survival in vivo.
- Contribution to journal › Letter
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
- Contribution to journal › Article
-
Mark
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor.
- Contribution to journal › Article
-
Mark
Cell-based therapies for Parkinson disease-past insights and future potential.
- Contribution to journal › Scientific review
-
Mark
In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry.
- Contribution to journal › Article
